Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

Summary

OBJECTIVES: I. Determine the efficacy of picibanil sclerotherapy in children with macrocystic lymphangioma.

Timeline

Start

2000-04

Primary completion

2006-06

Completion

2007-11

Publications

• Smith MC, Zimmerman MB, Burke DK, Bauman NM, Sato Y, Smith RJ; OK-432 Collaborative Study Group. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope. 2009 Jan;119(1):107-15. doi: 10.1002/lary.20041.

Drugs

Indications